Investigating into anti-cancer potential of lycopene: Molecular targets
2021 · Biomedicine & Pharmacotherapy · 43 citations
https://doi.org/10.1016/j.biopha.2021.111546
W
Wang Sheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
1.9K
Citations
23
h-index
31
i10-index
Wang Sheng is an academic researcher from China International Science and Technology Cooperation. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & MicroRNA in disease regulation & RNA Interference and Gene Delivery. The author has an h-index of 23, co-authored 60 publications.
ORCID: 0000-0003-4042-5102Papers by this author
worksDual‐Nanocomplex Delivery of Neoantigen Vaccines and Doxorubicin for Synergistic Chemo‐Immunotherapy against Colorectal Cancer
2025 · Advanced Healthcare Materials · 1 citations
https://doi.org/10.1002/adhm.202503947
Advances in neoantigen peptide-based nanovaccines for targeted tumor immunotherapy: Multifaceted strategies, challenges, and future perspectives
2025 · Chinese Chemical Letters · 0 citations
https://doi.org/10.1016/j.cclet.2025.112244
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat